Adapalene; Benzoyl Peroxide; Clindamycin Phosphate Patent Expiration

Adapalene; Benzoyl Peroxide; Clindamycin Phosphate is Used for treating acne vulgaris in patients 12 years of age and older. It was first introduced by Bausch Health Us Llc in its drug Cabtreo on Oct 20, 2023.


Adapalene; Benzoyl Peroxide; Clindamycin Phosphate Patents

Given below is the list of patents protecting Adapalene; Benzoyl Peroxide; Clindamycin Phosphate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cabtreo US11389467 Topical compositions Dec 28, 2040 Bausch
Cabtreo US8288434 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Aug 05, 2029 Bausch
Cabtreo US10220049 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun 03, 2029 Bausch
Cabtreo US10624918 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun 03, 2029 Bausch
Cabtreo US9561208 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun 03, 2029 Bausch



Adapalene; Benzoyl Peroxide; Clindamycin Phosphate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List